The U.S. Food and Drug Administration (FDA) has recorded the methotrexate sodium injection (product number 001) from sponsor Quad Pharms as discontinued.
The product is an injectable formulation with a strength of EQ 25 mg base per mL. It is not designated as a reference drug, and its marketing status is listed as discontinued under application number ANDA089309.
法规动态2026年8月30日•1 分钟阅读
FDA Discontinues Methotrexate Sodium Injection (ANDA089309)
The FDA has listed Quad Pharms' methotrexate sodium injection (product 001) as discontinued under ANDA089309.
由 PharmaCountry 团队整理 · 来源： FDA.gov
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分